These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1979942)

  • 1. [Results of a survey on the use of delayed-action neuroleptics in psychiatry].
    Bourin M; Venisse JL; Lecuyer F
    Encephale; 1990; 16(5):363-9. PubMed ID: 1979942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical study of the use of long acting neuroleptics (depot neuroleptics) in France.
    Ginestet D; Peron-Magnan P; Deniker P
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):183-6. PubMed ID: 10586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of prescriptions for neuroleptic drugs: tranquilizers rather than antipsychotics.
    Linden M; Thiels C
    Pharmacopsychiatry; 2001 Jul; 34(4):150-4. PubMed ID: 11518477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
    Heresco-Levy U; Brom D; Greenberg D
    Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prescription of psychopharmaceuticals. A survey of drug treatment at 10 psychiatric hospitals].
    Oyehaug E; Barstad AM; Bøe T; Hermansen R; Håberg M; Johansen U; Mellvang B; Nome T; Rønning BH; Wold I
    Tidsskr Nor Laegeforen; 1989 Apr; 109(11):1150-2. PubMed ID: 2734739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eleven years of experience with depot neuroleptics.
    Gross H; Kaltenbäck E; Pfolz H
    Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective comparative study of treatment with delayed-action neuroleptics and neuroleptics administrated orally in long-term psychosis].
    Chambon O; Marie-Cardine M; Terra JL; Corot P
    Encephale; 1988; 14(4):293-7. PubMed ID: 2904356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Depot preparations in psychiatry].
    Gunby B
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):176-7. PubMed ID: 4150719
    [No Abstract]   [Full Text] [Related]  

  • 16. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of depot neuroleptic medication in psychiatric inpatients.
    Citrome L; Levine J; Allingham B
    Psychopharmacol Bull; 1996; 32(3):321-6. PubMed ID: 8961774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot antipsychotics. Patient characteristics and prescribing pattern.
    Al-Sughayir MA
    Saudi Med J; 2000 Dec; 21(12):1178-81. PubMed ID: 11360095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects and side effects of depot neuroleptics as perceived by patients].
    Trenckmann U
    Psychiatr Prax; 1990 Sep; 17(5):184-7. PubMed ID: 1980015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neuroleptics.
    Lambert PA; Guinot G; Chabannes JP
    Acta Psychiatr Belg; 1981; 81(2):103-14. PubMed ID: 6117180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.